secwatch.observer — SEC 8-K summary
======================================

Issuer:     RAPID MICRO BIOSYSTEMS, INC. (RPID)
CIK:        0001380106
Form:       8-K
Filed at:   2024-05-03T23:59:59+00:00
Accession:  0001380106-24-000125
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rapid Micro Biosystems Q1 revenue $5.6M (+11% YoY), loss $13.3M; reaffirms FY guidance
--------------------------------------------------------------------------------

- Q1 revenue $5.6M (+11% YoY); net loss $13.3M ($0.31/share).
- Recurring revenue $3.7M (+15% YoY); record consumable revenue.
- Placed three Growth Direct systems; reaffirms FY2024 revenue guidance of at least $27M.
- Cash, equivalents and investments $79.5M; no debt; runway into H2 2026.
- Growth Direct Rapid Sterility platform on track for mid-2024 launch.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1380106/000138010624000125/0001380106-24-000125-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1380106/000138010624000125/rpid-20240503.htm
  HTML page:      https://secwatch.observer/filing/0001380106-24-000125

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer